Conditions: Amyloidosis; Basal Cell Carcinoma; Biliary Tract Carcinoma; Bladder Carcinoma; Breast Carcinoma; Cervical Carcinoma; Colorectal Carcinoma; Endometrial Carcinoma; Fallopian Tube Carcinoma; Gastroesophageal Junction Carcinoma; Glioblastoma; Head and Neck Carcinoma; Hematopoietic and Lymphatic System Neoplasm; Hepatocellular Carcinoma; Hodgkin Lymphoma; Lung Carcinoma; Malignant Solid Neoplasm; Mantle Cell Lymphoma; Melanoma; Merkel Cell Carcinoma; Multiple Myeloma; Myelodysplastic Syndrome; Ovarian Carcinoma; Pancreatic Carcinoma; Primary Peritoneal Carcinoma; Prostate Carcinoma; Renal Cell Carcinoma; Squamous Cell Carcinoma; Urothelial Carcinoma
Interventions: Drug: Cancer Therapeutic Procedure; Drug: Cancer Therapeutic Procedure; Other: Questionnaire Administration
Sponsors: Mayo Clinic
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
